Bosh sahifaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
1,95 $
Seans yopilganidan keyin:(1,54%)+0,030
1,98 $
Yopilgan:2-apr, 19:59:44 (GMT-4) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
1,59 $
Kunlik diapazon
1,57 $ - 1,98 $
Yillik diapazon
1,11 $ - 99,75 $
Bozor kapitalizatsiyasi
51,92 mln USD
Oʻrtacha hajm
664,41 ming
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | -521,00 ming | -122,56% |
Joriy xarajat | 1,78 mln | 0,79% |
Sof foyda | -26,60 mln | -2 094,39% |
Sof foyda marjasi | 5,10 ming | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,82 mln | -3,52% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 7,96 mln | 1 750,70% |
Jami aktivlari | 9,04 mln | 163,95% |
Jami passivlari | 31,86 mln | 796,99% |
Umumiy kapital | -22,83 mln | — |
Tarqatilgan aksiyalar | 26,63 mln | — |
Narxi/balansdagi bahosi | -1,73 | — |
Aktivlardan daromad | -72,83% | — |
Kapitaldan daromad | 46,90% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -26,60 mln | -2 094,39% |
Operatsiyalardan naqd pul | -2,29 mln | -170,40% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 7,82 mln | 1 463,20% |
Naqd pulning sof oʻzgarishi | 5,52 mln | 1 696,24% |
Boʻsh pul | -1,47 mln | -89,55% |
Haqida
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Tashkil etilgan
2000
Sayt
Xodimlar soni
3
